Moderate drinking positive for prostate cancer

Alcohol doesn’t appear to increase the risk of developing metastatic prostate cancer or increase the risk of death in patients with the disease.

A prospective cohort study, published in the Journal of Clinical Oncology, looked at alcohol intake among 47 568 cancer-free men at risk of prostate cancer and 5182 men diagnosed with nonmetastatic prostate cancer men.

Researchers found that alcohol drinkers had a lower risk of developing metastatic prostate cancer (any versus none: HR, 0.84 [95% CI, 0.71–0.99]). Total alcohol intake among patients with prostate cancer was not associated with progression to metastatic prostate cancer (HR, 0.99 [95% CI, 0.57 to 1.72]), whereas moderate red wine intake was associated with a lower risk (HR, 0.50 [95% CI, 0.29–0.86]). Compared with no alcohol, 15 to 30 grams of alcohol per day, after prostate cancer diagnosis, was associated with a lower risk of death (HR, 0.71 [95% CI, 0.50–1.00]), as was red wine (HR, 0.74 [95% CI, 0.57–0.97]).

The authors conclude that cancer-free men who drink moderate amounts of alcohol have a slightly lower risk of metastatic prostate cancer compared with abstainers. Among men with prostate cancer, red wine was associated with a lower risk of progression to metastatic disease. These associations require additional study but provide reassurance that moderate alcohol consumption is safe for patients with prostate cancer, they say.

Web design and marketing agency Leamington Spa